Till date, increased DDX27 levels have been correlated with poor prognosis and outcome in gastric, breast, colorectal, and hepatocellular cancer patients, indicating a positive association with carcinogenesis (46–49). Here, DDX27 is linked to hepatocellular carcinoma.